Management of Clinical T2N0 Esophageal and Gastroesophageal Junction Adenocarcinoma: What Is the Optimal Treatment?

Perez Holguin, Rolfy A; Olecki, Elizabeth J; Stahl, Kelly A; Wong, William G; Vining, Charles C; Dixon, Matthew E B; Peng, June S

Perez Holguin, Rolfy A; Olecki, Elizabeth J; Stahl, Kelly A; Wong, William G; Vining, Charles C; Dixon, Matthew E B; Peng, June S.

Afiliação

Perez Holguin RA; Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, PA, USA.
Olecki EJ; Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, PA, USA.
Stahl KA; Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, PA, USA.
Wong WG; Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, PA, USA.
Vining CC; Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, PA, USA.
Dixon MEB; Division of Surgical Oncology, Department of Surgery, College of Medicine, The Pennsylvania State University, 500 University Drive, Hershey, PA, H07017033, USA.
Peng JS; Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, PA, USA.

J Gastrointest Surg ; 26(10): 2050-2060, 2022 10.

Article em En | MEDLINE | ID: mdl-36042124

Assuntos

Adenocarcinoma; Esofagectomia; Adenocarcinoma/patologia; Neoplasias Esofágicas; Esofagectomia/efeitos adversos; Junção Esofagogástrica/cirurgia; Humanos; Estadiamento de Neoplasias

Palavras-chave

Adjuvant therapy; Esophageal adenocarcinoma; Neoadjuvant therapy; Pathologic upstaging

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Esofagectomia Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google